The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)—a suitable endophenotype of schizophrenia
Open accessAbstract
The concept of schizotypy or "psychosis proneness" captures individual differences in perceptual, cognitive, and affective experiences that may relate to a range of psychotic disorders. The concept is an important way to assess the contribution of pre-existing psychological and genetically based biological features to the development of illnesses such as schizophrenia (so called endophenotypes). The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) is a widely used multi-dimensional measure of the construct and consists of four scales which mirror several groups of psychotic symptoms: Unusual Experiences (UnEx; positive symptoms), Cognitive Disorganization (CogDis; cognitive symptoms), Introvertive Anhedonia (IntAn; negative symptoms), and Impulsive Nonconformity (ImpNon; impulsive and antisocial symptoms). For the purpose of evaluating the suitability of schizotypy as an endophenotype of schizophrenia the current version of the O-LIFE was translated into German: its psychometric properties (including re-test reliability and construct validity) were examined in a large sample (n > 1200) and compared to those of the English original. The German version was both highly reliable and consistent with the original. The study aimed to show that schizotypy as measured by the O-LIFE can indeed be regarded as an endophenotype of schizophrenia in terms of genetic associations regarding relevant dopamine-related candidate polymorphisms of schizotypy [i.e., Val(158)Met-polymorphism of the COMT gene, uVNTR of the MAOA gene, Taq1A-polymorphism of the DRD2 gene, VNTR of the SLC6A3 (DAT) gene]. We also wanted to compare the genetic associations of the O-LIFE to those published using other operationalizations of schizotypy. Our results show a large number of significant associations and borderline-significant trends between the O-LIFE sub-scales and a range of genes, thereby supporting using the O-LIFE in the search for endophenotypic markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Role of genotype in the cycle of violence in maltreated children
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., Taylor, A., & Poulton, R. (2002) · Science · doi:10.1126/science.1072290 · Cited by 4,842
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · cited 3×
“ORIGINAL RESEARCH ARTICLE published: 24 January 2013 doi: 10.3389/fnhum.2013.00001 Dopaminergic foundations of schizotypy as measured by the German version of the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE)—a suitable endophenotype of schizophrenia”
BackgroundMethodResultInfluentialThe SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,019
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · cited 1×
“This effect is explainable due to the enhancing effect of dopamine on cognitive functions and the neurotrophic effect of dopamine during brain ontogeny (for a review, see Nieoullon, 2002).”
BackgroundOxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones
GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 1×
“…MAO-A would have the highest levels of synaptic dopamine and thereby moderately high UnEx-scores due to the abundance of dopamine itself as well as to an increased rate of dopamine-quinone formation (Graham, 1978; Graham et al., 1978), a secondary mechanism in dopamine-neurotoxicity (Grant, 2011).”
BackgroundA functional polymorphism in the monoamine oxidase A gene promoter
Sabol, S. Z., Hu, S., & Hamer, D. (1998) · Human Genetics · doi:10.1007/s004390050816 · Cited by 1,079
Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P. A., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., & Bertram, L. (2008) · Nature Genetics · doi:10.1038/ng.171 · Cited by 1,054
GRAHAM, D. G., TIFFANY, S. M., BELL, W. R., & GUTKNECHT, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR
Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., & Uhl, G. R. (1992) · Genomics · doi:10.1016/s0888-7543(05)80138-7 · Cited by 708
Pohjalainen, T., Rinne, J. O., Någren, K., Lehikoinen, P., Anttila, K., Syvälahti, E. K. G., & Hietala, J. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000350 · Cited by 673
New scales for the assessment of schizotypy
Mason, O., Claridge, G., & Jackson, M. (1995) · Personality and Individual Differences · doi:10.1016/0191-8869(94)00132-c · Cited by 635
Self-citationDeckert, J., Catalano, M., Syagailo, Y. V., Bosi, M., Okladnova, O., Di Bella, D., Nothen, M. M., Maffei, P., Franke, P., Fritze, J., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.621 · Cited by 582
Premorbid IQ in Schizophrenia: A Meta-Analytic Review
Woodberry, K. A., Giuliano, A. J., & Seidman, L. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07081242 · Cited by 570
Genetically Determined Differences in Learning from Errors
Klein, T. A., Neumann, J., Reuter, M., Hennig, J., von Cramon, D. Y., & Ullsperger, M. (2007) · Science · doi:10.1126/science.1145044 · Cited by 426
Self-citationMason, O., & Claridge, G. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.845 · Cited by 379
Self-citationShort scales for measuring schizotypy
Mason, O., Linney, Y., & Claridge, G. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.020 · Cited by 351
Self-citationDYNAMICS AND CLASSIFICATION OF DISORDERED BEHAVIOR
RADO, S. (1953) · American Journal of Psychiatry · doi:10.1176/ajp.110.6.406 · Cited by 349
Karoum, F., Chrapusta, S. J., & Egan, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030972.x · Cited by 347
Comings, D. E., & MacMurray, J. P. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3015 · Cited by 332
Violence in first-episode psychosis: A systematic review and meta-analysis
Large, M. M., & Nielssen, O. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.026 · Cited by 278
The global burden of mental disorders.
Ustün, T. B. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.9.1315 · Cited by 258
Lui, S., Deng, W., Huang, X., Jiang, L., Ma, X., Chen, H., Zhang, T., Li, X., Li, D., Zou, L., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020183 · Cited by 257
Maker, H. S., Weiss, C., Silides, D. J., & Cohen, G. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb01631.x · Cited by 256
Schizotypy and mental health amongst poets, visual artists, and mathematicians
Nettle, D. (2006) · Journal of Research in Personality · doi:10.1016/j.jrp.2005.09.004 · Cited by 256
The relationship between measures of creativity and schizotypy
Batey, M., & Furnham, A. (2008) · Personality and Individual Differences · doi:10.1016/j.paid.2008.08.014 · Cited by 243
Reuter, M., & Hennig, J. (2005) · Neuroreport · doi:10.1097/00001756-200507130-00020 · Cited by 155
Self-citationKirsch, P., Reuter, M., Mier, D. U., Lonsdorf, T. B., Stark, R. M., Gallhofer, B., Vaitl, D., & Hennig, J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.030 · Cited by 154
Self-citationCognition in schizophrenia : impairments, importance, and treatment strategies
Sharma, T., & Harvey, P. D. (2000) · Oxford University Press eBooks · Cited by 146
Cognitive functioning in first episode psychosis: initial presentation
Addington, J., Brooks, B. L., & Addington, D. E. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00340-7 · Cited by 146
A quantitative genetic analysis of schizotypal personality traits
Linney, Y., Murray, R. M., PETERS, E. R., MacDONALD, A. M., Rijsdijk, F. V., & Sham, P. C. (2003) · Psychological Medicine · doi:10.1017/s0033291703007906 · Cited by 146
Avramopoulos, D., Stefanis, N. C., Hantoumi, I., Smyrnis, N., Evdokimidis, I., & STEFANIS, C. N. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001070 · Cited by 116
Hamidovic, A., Dlugos, A., Skol, A., Palmer, A. A., & de Wit, H. (2009) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0017840 · Cited by 108
The Rust Inventory of Schizotypal Cognitions (RISC)
Rust, J. N. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.317 · Cited by 104
Oxidative reactions and schizophrenia: A review-discussion
Smythies, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00005-4 · Cited by 103
Theoretical background and issues
CLARIDGE, G. S. (2018) · Routledge eBooks · doi:10.4324/9781315268217-11 · Cited by 101
Prata, D. P., Mechelli, A., Fu, C. H. Y., Picchioni, M., Toulopoulou, T., Bramon, E., Walshe, M., Murray, R. M., Collier, D. A., & McGuire, P. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903007106 · Cited by 96
Social Deficits and Perseverative Behaviors, but not Overt Aggression, in MAO-A Hypomorphic Mice
Bortolato, M., Chen, K., Godar, S. C., Chen, G., Wu, W., Rebrin, I., Farrell, M. R., Scott, A. L., Wellman, C. L., & Shih, J. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.157 · Cited by 90
Effect of COMT val158met genotype on cognition and personality
Sheldrick, A. J., Krug, A., Markov, V., Leube, D., Michel, T. M., Zerres, K., Eggermann, T., & Kircher, T. T. J. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.05.002 · Cited by 89
Smythies, J. (1999) · Neurotoxicity Research · doi:10.1007/bf03033337 · Cited by 88
Smyrnis, N., Avramopoulos, D., Evdokimidis, I., Stefanis, C. N., Tsekou, H., & Stefanis, N. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.019 · Cited by 72
Schizotypal dimensions: An intermediate phenotype associated with the COMT high activity allele
Schürhoff, F., Szöke, A., Chevalier, F., Roy, I., Méary, A., Bellivier, F., Giros, B., & Leboyer, M. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30395 · Cited by 64
Theoretical background and issues
CLARIDGE, G. S. (1997) · Oxford University Press eBooks · doi:10.1093/med:psych/9780198523536.003.0001 · Cited by 64
Ma, X., Sun, J., Yao, J., Wang, Q., Hu, X., Deng, W., Sun, X., Liu, X., Murray, R. M., Collier, D. A., et al. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.02.003 · Cited by 51
Suzuki, M., Zhou, S.-Y., Hagino, H., Niu, L., Takahashi, T., Kawasaki, Y., Matsui, M., Seto, H., ONO, T., & Kurachi, M. (2004) · Psychological Medicine · doi:10.1017/s0033291704003885 · Cited by 46
Schizotypy, attention deficit hyperactivity disorder, and dopamine genes
ETTINGER, U., JOOBER, R., DE GUZMAN, R., & O’DRISCOLL, G. A. (2006) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2006.01594.x · Cited by 32
Response to Comment on "Genetically Determined Differences in Learning from Errors"
Klein, T. A., Reuter, M., von Cramon, D. Y., & Ullsperger, M. (2008) · Science · doi:10.1126/science.1156079 · Cited by 24
Variation in genes involved in dopamine clearance influence the startle response in older adults
Armbruster, D., Mueller‐Alcazar, A., Strobel, A., Lesch, K., Kirschbaum, C., & Brocke, B. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0625-6 · Cited by 16
Yang, J.-W., Lee, S. H., Ryu, S., Lee, B., Kim, S. H., Joe, S.-H., Jung, I., Choi, I., & Ham, B. (2007) · Neuropsychobiology · doi:10.1159/000109973 · Cited by 12
Developmental Monoamine Signaling Impacts Adult Affective and Aggressive Behaviors
Yu, Q. (2012) · doi:10.7916/d8z60w4b · Cited by 2
Cited by
Resting-state functional connectivity in major depressive disorder: A review
Mulders, P. C., van Eijndhoven, P. F., Schene, A. H., Beckmann, C. F., & Tendolkar, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.014 · Cited by 884
Horvath, J. C., Forte, J. D., & Carter, O. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.11.021 · Cited by 528
Morawetz, C., Bode, S., Derntl, B., & Heekeren, H. R. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.014 · Cited by 458
The Virtual Epileptic Patient: Individualized whole-brain models of epilepsy spread
Jirsa, V. K., Proix, T., Perdikis, D., Woodman, M. M., Wang, H., Gonzalez-Martinez, J., Bernard, C., Bénar, C., Guye, M., Chauvel, P., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.04.049 · Cited by 430
Alves, P. N., Foulon, C., Karolis, V., Bzdok, D., Margulies, D. S., Volle, E., & Thiebaut de Schotten, M. (2019) · Communications Biology · doi:10.1038/s42003-019-0611-3 · Cited by 357
Metadata
- Authors
- Grant, P., Kuepper, Y., Mueller, E. A., Wielpuetz, C., Mason, O., & Hennig, J.
- Venue
- Frontiers in Human Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 7
- Pages
- 1-1
- ISSN
- 1662-5161 (ISSN-L)
- OpenAlex
- W2095679266
- Cited by
- 716
- References
- 53
- FWCI
- 55.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.